Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 04 2022
Historique:
received: 13 01 2022
accepted: 12 04 2022
entrez: 29 4 2022
pubmed: 30 4 2022
medline: 4 5 2022
Statut: epublish

Résumé

The human SLC22A6/OAT1 plays an important role in the elimination of a broad range of endogenous substances and xenobiotics thus attracting attention from the pharmacological community. Furthermore, OAT1 is also involved in key physiological events such as the remote inter-organ communication. Despite its significance, the knowledge about hOAT1 structure and the transport mechanism at the atomic level remains fragmented owing to the lack of resolved structures. By means of protein-threading modeling refined by μs-scaled Molecular Dynamics simulations, the present study provides the first robust model of hOAT1 in outward-facing conformation. Taking advantage of the AlphaFold 2 predicted structure of hOAT1 in inward-facing conformation, we here provide the essential structural and functional features comparing both states. The intracellular motifs conserved among Major Facilitator Superfamily members create a so-called "charge-relay system" that works as molecular switches modulating the conformation. The principal element of the event points at interactions of charged residues that appear crucial for the transporter dynamics and function. Moreover, hOAT1 model was embedded in different lipid bilayer membranes highlighting the crucial structural dependence on lipid-protein interactions. MD simulations supported the pivotal role of phosphatidylethanolamine components to the protein conformation stability. The present model is made available to decipher the impact of any observed polymorphism and mutation on drug transport as well as to understand substrate binding modes.

Identifiants

pubmed: 35488116
doi: 10.1038/s41598-022-10755-2
pii: 10.1038/s41598-022-10755-2
pmc: PMC9054760
doi:

Substances chimiques

Lipid Bilayers 0
Organic Anion Transport Protein 1 0
Organic Anion Transporters 0
SLC22A6 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7057

Informations de copyright

© 2022. The Author(s).

Références

Eur J Pharm Sci. 2018 Jan 15;112:8-19
pubmed: 29109021
Biochemistry. 1995 Aug 1;34(30):9734-47
pubmed: 7626644
Nucleic Acids Res. 2015 Jan;43(Database issue):D204-12
pubmed: 25348405
J Chem Phys. 2020 Oct 14;153(14):141103
pubmed: 33086825
Structure. 2012 Nov 7;20(11):1893-904
pubmed: 23000385
J Biol Chem. 2020 Feb 14;295(7):1829-1842
pubmed: 31896576
Int J Nephrol Renovasc Dis. 2019 Dec 12;12:257-262
pubmed: 31849512
Sci Rep. 2017 Jul 10;7(1):4939
pubmed: 28694431
J Mol Graph. 1996 Dec;14(6):354-60, 376
pubmed: 9195488
Mol Pharmacol. 1999 Sep;56(3):570-80
pubmed: 10462545
Clin Pharmacol Ther. 2018 Nov;104(5):890-899
pubmed: 30091177
Science. 2003 Aug 1;301(5633):616-20
pubmed: 12893936
Sci Rep. 2018 May 24;8(1):8085
pubmed: 29795395
Biochemistry. 1991 May 14;30(19):4654-8
pubmed: 2029513
J Biol Chem. 2006 Dec 8;281(49):38071-9
pubmed: 17038320
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Phys Chem B. 2009 Oct 8;113(40):13279-90
pubmed: 19757835
Physiol Rev. 2015 Jan;95(1):83-123
pubmed: 25540139
J Clin Med. 2020 Aug 12;9(8):
pubmed: 32806541
Kidney Int. 1999 Jul;56(1):104-17
pubmed: 10411684
PLoS One. 2015 Nov 04;10(11):e0140569
pubmed: 26536134
J Mol Biol. 2011 Apr 15;407(5):698-715
pubmed: 21315728
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6231-E6239
pubmed: 28701380
Nat Protoc. 2019 Nov;14(11):3183-3204
pubmed: 31605097
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Toxins (Basel). 2020 Jun 12;12(6):
pubmed: 32545617
ACS Cent Sci. 2018 Jun 27;4(6):709-717
pubmed: 29974066
J Phys Chem B. 2008 Jul 31;112(30):9020-41
pubmed: 18593145
Nature. 2014 Jun 5;510(7503):121-5
pubmed: 24847886
Biopolymers. 1992 May;32(5):523-35
pubmed: 1515543
BMC Bioinformatics. 2008 Jan 23;9:40
pubmed: 18215316
J Chem Theory Comput. 2014 Feb 11;10(2):865-879
pubmed: 24803855
Protein Sci. 2015 Oct;24(10):1560-79
pubmed: 26234418
Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):561-570
pubmed: 29746174
Curr Opin Nephrol Hypertens. 2018 Jul;27(4):305-313
pubmed: 29847376
Chem Rev. 2021 May 12;121(9):5289-5335
pubmed: 33886296
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Clin Pharmacol Ther. 2007 Feb;81(2):298-304
pubmed: 17259955
Nat Commun. 2018 Oct 8;9(1):4151
pubmed: 30297844
Handb Exp Pharmacol. 2011;(201):29-104
pubmed: 21103968
EMBO J. 1998 Sep 15;17(18):5255-64
pubmed: 9736605
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Cell Biochem Biophys. 2011 Nov;61(2):251-9
pubmed: 21499753
Life Sci Alliance. 2021 Feb 3;4(4):
pubmed: 33536238
Pharmacol Res. 2018 Jul;133:318-327
pubmed: 29530601
Nature. 2012 Oct 18;490(7420):361-6
pubmed: 23075985
J Chem Theory Comput. 2012 May 8;8(5):1542-1555
pubmed: 22582031
Nat Struct Mol Biol. 2013 Jun;20(6):766-8
pubmed: 23624861
Clin Pharmacol Ther. 2013 Jul;94(1):52-63
pubmed: 23588305
Nature. 2015 Oct 15;526(7573):397-401
pubmed: 26416735
J Chem Theory Comput. 2019 Dec 10;15(12):6752-6759
pubmed: 31647864
Nat Rev Mol Cell Biol. 2016 Feb;17(2):123-32
pubmed: 26758938
Curr Opin Struct Biol. 2017 Aug;45:100-108
pubmed: 28040635
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14664-9
pubmed: 23950222
Annu Rev Biophys. 2015;44:257-83
pubmed: 26098515
Mol Pharm. 2016 Sep 6;13(9):3130-40
pubmed: 27467266
Nat Rev Drug Discov. 2015 Jan;14(1):29-44
pubmed: 25475361
J Biol Chem. 2004 Apr 9;279(15):14961-6
pubmed: 14749323
Chem Rev. 2019 May 8;119(9):6086-6161
pubmed: 30978005
J Mol Microbiol Biotechnol. 2014;24(2):82-90
pubmed: 24603210
Nat Struct Mol Biol. 2016 Aug;23(8):744-51
pubmed: 27399258
J Gen Physiol. 2019 Jul 1;151(7):878-886
pubmed: 31147449
Clin Pharmacol Ther. 2018 Oct;104(4):687-698
pubmed: 29285751
J Chem Theory Comput. 2011 Jul 12;7(7):2284-95
pubmed: 26606496
J Biol Chem. 2006 Oct 20;281(42):31178-83
pubmed: 16920720
Sci Rep. 2019 Jan 30;9(1):998
pubmed: 30700737
J Comput Chem. 2014 Oct 15;35(27):1997-2004
pubmed: 25130509
Nature. 2015 Oct 15;526(7573):391-6
pubmed: 26176916
Pharm Res. 1999 Feb;16(2):176-85
pubmed: 10100300

Auteurs

Angelika Janaszkiewicz (A)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France.

Ágota Tóth (Á)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France.

Quentin Faucher (Q)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France.

Marving Martin (M)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France.
InSiliBio, Ester Technopôle, 1 avenue d'Ester, 87000, Limoges, France.

Benjamin Chantemargue (B)

InSiliBio, Ester Technopôle, 1 avenue d'Ester, 87000, Limoges, France.

Chantal Barin-Le Guellec (C)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France.
CHU de Tours, 2 Boulevard Tonnellé, 37044, Tours, France.

Pierre Marquet (P)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France.
Department of Pharmacology and Toxicology, CHU Limoges, 87000, Limoges, France.

Florent Di Meo (F)

INSERM U1248 Pharmacology & Transplantation, CBRS, Faculté de Médecine et Pharmacie, Univ. Limoges, 2 rue du prof. Descottes, 87000, Limoges, France. florent.di-meo@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH